VOYA Investment Management
KYMR icon

VOYA Investment Management’s Kymera Therapeutics KYMR Stock Holding History

VOYA Investment Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.6M Buy
198,808
+169,868
+587% +$13.5M 0.02% 501
2025
Q4 		$2.25M Sell
28,940
-7,515
-21% -$507K ﹤0.01% 1173
2025
Q3 		$2.06M Buy
36,455
+6,669
+22% +$301K ﹤0.01% 1216
2025
Q2 		$1.3M Sell
29,786
-8,838
-23% -$304K ﹤0.01% 1457
2025
Q1 		$1.06M Sell
38,624
-22,519
-37% -$821K ﹤0.01% 1539
2024
Q4 		$2.46M Sell
61,143
-1,034
-2% -$46.7K ﹤0.01% 1227
2024
Q3 		$2.94M Sell
62,177
-4,529
-7% -$200K ﹤0.01% 1209
2024
Q2 		$1.99M Sell
66,706
-3,734
-5% -$129K ﹤0.01% 1319
2024
Q1 		$2.83M Sell
70,440
-2,534
-3% -$90.7K ﹤0.01% 1209
2023
Q4 		$1.86M Sell
72,974
-21
-0% -$376 ﹤0.01% 1397
2023
Q3 		$1.01M Buy
72,995
+316
+0.4% +$6.35K ﹤0.01% 1624
2023
Q2 		$1.67M Buy
72,679
+583
+0.8% +$16.7K ﹤0.01% 1423
2023
Q1 		$2.14M Sell
72,096
-183
-0.3% -$5.9K ﹤0.01% 1334
2022
Q4 		$1.8M Buy
72,279
+20,435
+39% +$545K ﹤0.01% 1377
2022
Q3 		$1.13M Buy
51,844
+37,609
+264% +$991K ﹤0.01% 1569
2022
Q2 		$280K Buy
14,235
+247
+2% +$5.77K ﹤0.01% 2215
2022
Q1 		$592K Buy
13,988
+414
+3% +$17.5K ﹤0.01% 1808
2021
Q4 		$861K Buy
13,574
+273
+2% +$15.9K ﹤0.01% 1647
2021
Q3 		$781K Buy
13,301
+1,906
+17% +$111K ﹤0.01% 1761
2021
Q2 		$553K Buy
+11,395
New +$495K ﹤0.01% 2025
2021
Q1 		– Sell
-3,881
Closed -$241K – 2764
2020
Q4 		$241K Buy
+3,881
New +$189K ﹤0.01% 2325

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

VOYA Investment Management's KYMR Position: Q1 2026 in Review

VOYA Investment Management increased its Kymera Therapeutics (KYMR) stake by 587% in Q1 2026, buying an estimated $13.5M and bringing the position to 198,808 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #501.

VOYA Investment Management first reported a position in KYMR in Q4 2020 and has held it in 21 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • VOYA Investment Management held 198,808 shares of Kymera Therapeutics worth $16.6M as of Q1 2026.
  • VOYA Investment Management bought 169,868 Kymera Therapeutics shares in Q1 2026, an estimated $13.5M.
  • Kymera Therapeutics made up 0.02% of VOYA Investment Management's portfolio in Q1 2026, its #501 holding.
  • VOYA Investment Management first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.